MoneyWorks4Me

Medicamen Biotech informs about issuance of duplicate share certificates

03 Mar 2023 Evaluate

In terms of Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Medicamen Biotech has informed that the Company has received request for issuance of duplicate share certificates in lieu of share certificates reported lost. The company has enclosed the details of the lost share certificates.

The above information is a part of company’s filings submitted to BSE.


Peers
Company Name CMP
Sun Pharma. Inds. 1853.00
Dr. Reddys Labs. 1200.40
Cipla 1404.00
Lupin 2098.00
Zydus Lifesciences 1180.00
View more..